Therecently described XP/CS patients with mutations in XPF orERCC1 (Kashiyama etal., 2013) pose a challenge to the “CS as a transcriptionsyndrome” point of view, because XPF/ERCC1 is implicated in NER and not in basaltranscription. The gene discussed is ERCC1; the disease is Cowden syndrome 1.